воскресенье, 10 апреля 2016 г.

Edwards Lifesciences Corp (EW) Price Target Cut to $87.00 by Analysts at Barclays

Edwards Lifesciences Corp (EW) Price Target Cut to $87.00 by Analysts at Barclays


The brokerage presently has an "equal weight" rating on the medical research company's stock. Barclays' target price would suggest a potential downside of 16.72% from the company's current price.



from Biotech News